ID   NMT1_HUMAN              Reviewed;         496 AA.
AC   P30419; A8K7C1; Q9UE09;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2001, sequence version 2.
DT   10-MAY-2017, entry version 178.
DE   RecName: Full=Glycylpeptide N-tetradecanoyltransferase 1;
DE            EC=2.3.1.97 {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:9353336, ECO:0000269|PubMed:9506952};
DE   AltName: Full=Myristoyl-CoA:protein N-myristoyltransferase 1;
DE            Short=NMT 1;
DE            Short=Type I N-myristoyltransferase;
DE   AltName: Full=Peptide N-myristoyltransferase 1;
GN   Name=NMT1; Synonyms=NMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=9353336; DOI=10.1074/jbc.272.45.28680;
RA   Glover C.J., Hartman K.D., Felsted R.L.;
RT   "Human N-myristoyltransferase amino-terminal domain involved in
RT   targeting the enzyme to the ribosomal subcellular fraction.";
RL   J. Biol. Chem. 272:28680-28689(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, AND
RP   SUBCELLULAR LOCATION.
RC   TISSUE=Brain;
RX   PubMed=9506952; DOI=10.1074/jbc.273.12.6595;
RA   Giang D.K., Cravatt B.F.;
RT   "A second mammalian N-myristoyltransferase.";
RL   J. Biol. Chem. 273:6595-6598(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS LONG AND SHORT).
RC   TISSUE=Muscle, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 58-496, AND MUTAGENESIS OF GLY-492.
RX   PubMed=1570339; DOI=10.1073/pnas.89.9.4129;
RA   Duronio R.J., Reed S.I., Gordon J.I.;
RT   "Mutations of human myristoyl-CoA:protein N-myristoyltransferase cause
RT   temperature-sensitive myristic acid auxotrophy in Saccharomyces
RT   cerevisiae.";
RL   Proc. Natl. Acad. Sci. U.S.A. 89:4129-4133(1992).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 81-89.
RX   PubMed=9677304; DOI=10.1042/bj3330491;
RA   Mcilhinney R.A.J., Young K., Egerton M., Camble R., White A.,
RA   Soloviev M.;
RT   "Characterization of human and rat brain myristoyl-CoA:protein N-
RT   myristoyltransferase: evidence for an alternative splice variant of
RT   the enzyme.";
RL   Biochem. J. 333:491-495(1998).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47 AND SER-83, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-47, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (1.61 ANGSTROMS) OF 115-496 IN COMPLEX WITH
RP   MYRISTOYL-COA.
RG   Structural genomics consortium (SGC);
RT   "Crystal structure of human type-I N-myristoyltransferase with bound
RT   myristoyl-CoA and inhibitor DDD90055.";
RL   Submitted (SEP-2009) to the PDB data bank.
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.64 ANGSTROMS) OF 109-496 IN COMPLEX WITH
RP   MYRISTOYL-COA, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=25255805; DOI=10.1038/ncomms5919;
RA   Thinon E., Serwa R.A., Broncel M., Brannigan J.A., Brassat U.,
RA   Wright M.H., Heal W.P., Wilkinson A.J., Mann D.J., Tate E.W.;
RT   "Global profiling of co- and post-translationally N-myristoylated
RT   proteomes in human cells.";
RL   Nat. Commun. 5:4919-4919(2014).
CC   -!- FUNCTION: Adds a myristoyl group to the N-terminal glycine residue
CC       of certain cellular and viral proteins.
CC       {ECO:0000269|PubMed:25255805, ECO:0000269|PubMed:9353336,
CC       ECO:0000269|PubMed:9506952}.
CC   -!- CATALYTIC ACTIVITY: Tetradecanoyl-CoA + glycylpeptide = CoA + N-
CC       tetradecanoylglycylpeptide. {ECO:0000269|PubMed:25255805,
CC       ECO:0000269|PubMed:9353336, ECO:0000269|PubMed:9506952}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:9353336,
CC       ECO:0000269|PubMed:9506952}. Cytoplasm, cytosol
CC       {ECO:0000269|PubMed:9353336}. Membrane
CC       {ECO:0000269|PubMed:9506952}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:9506952}. Note=Copurifies with ribosomes.
CC       {ECO:0000269|PubMed:9353336}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P30419-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P30419-2; Sequence=VSP_003570;
CC   -!- TISSUE SPECIFICITY: Heart, gut, kidney, liver and placenta.
CC   -!- SIMILARITY: Belongs to the NMT family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC09294.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NMT1ID43604ch17q21.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF043324; AAC09294.1; ALT_INIT; mRNA.
DR   EMBL; AF020500; AAB95316.1; -; mRNA.
DR   EMBL; AK291936; BAF84625.1; -; mRNA.
DR   EMBL; CH471178; EAW51554.1; -; Genomic_DNA.
DR   EMBL; BC006538; AAH06538.1; -; mRNA.
DR   EMBL; BC006569; AAH06569.1; -; mRNA.
DR   EMBL; BC007258; AAH07258.2; -; mRNA.
DR   EMBL; BC008312; AAH08312.2; -; mRNA.
DR   EMBL; M86707; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; Y17208; CAA76685.1; -; mRNA.
DR   EMBL; Y17209; CAA76686.1; -; mRNA.
DR   CCDS; CCDS11494.1; -. [P30419-1]
DR   PIR; JC1343; JC1343.
DR   RefSeq; NP_066565.1; NM_021079.4. [P30419-1]
DR   UniGene; Hs.532790; -.
DR   PDB; 1RXT; X-ray; 3.00 A; A/B/C/D=1-496.
DR   PDB; 3IU1; X-ray; 1.42 A; A/B=115-496.
DR   PDB; 3IU2; X-ray; 1.73 A; A/B=115-496.
DR   PDB; 3IWE; X-ray; 1.79 A; A/B=115-496.
DR   PDB; 3JTK; X-ray; 1.61 A; A/B=115-496.
DR   PDB; 4C2Y; X-ray; 1.64 A; A/B=109-496.
DR   PDB; 4C2Z; X-ray; 2.08 A; A/B=109-496.
DR   PDBsum; 1RXT; -.
DR   PDBsum; 3IU1; -.
DR   PDBsum; 3IU2; -.
DR   PDBsum; 3IWE; -.
DR   PDBsum; 3JTK; -.
DR   PDBsum; 4C2Y; -.
DR   PDBsum; 4C2Z; -.
DR   ProteinModelPortal; P30419; -.
DR   SMR; P30419; -.
DR   BioGrid; 110899; 81.
DR   IntAct; P30419; 20.
DR   MINT; MINT-5004170; -.
DR   STRING; 9606.ENSP00000258960; -.
DR   BindingDB; P30419; -.
DR   ChEMBL; CHEMBL2593; -.
DR   DrugBank; DB03062; (1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone.
DR   SwissLipids; SLP:000001287; -.
DR   iPTMnet; P30419; -.
DR   PhosphoSitePlus; P30419; -.
DR   SwissPalm; P30419; -.
DR   BioMuta; NMT1; -.
DR   DMDM; 12231020; -.
DR   EPD; P30419; -.
DR   MaxQB; P30419; -.
DR   PaxDb; P30419; -.
DR   PeptideAtlas; P30419; -.
DR   PRIDE; P30419; -.
DR   TopDownProteomics; P30419-2; -. [P30419-2]
DR   DNASU; 4836; -.
DR   Ensembl; ENST00000258960; ENSP00000258960; ENSG00000136448. [P30419-1]
DR   Ensembl; ENST00000592782; ENSP00000468424; ENSG00000136448. [P30419-1]
DR   GeneID; 4836; -.
DR   KEGG; hsa:4836; -.
DR   UCSC; uc002ihz.4; human. [P30419-1]
DR   CTD; 4836; -.
DR   DisGeNET; 4836; -.
DR   GeneCards; NMT1; -.
DR   HGNC; HGNC:7857; NMT1.
DR   HPA; HPA022949; -.
DR   HPA; HPA022963; -.
DR   MIM; 160993; gene.
DR   neXtProt; NX_P30419; -.
DR   OpenTargets; ENSG00000136448; -.
DR   PharmGKB; PA31661; -.
DR   eggNOG; KOG2779; Eukaryota.
DR   eggNOG; COG5092; LUCA.
DR   GeneTree; ENSGT00390000017837; -.
DR   HOGENOM; HOG000189123; -.
DR   HOVERGEN; HBG003404; -.
DR   InParanoid; P30419; -.
DR   KO; K00671; -.
DR   OMA; EMCTEVY; -.
DR   OrthoDB; EOG091G06JB; -.
DR   PhylomeDB; P30419; -.
DR   BRENDA; 2.3.1.97; 2681.
DR   Reactome; R-HSA-162599; Late Phase of HIV Life Cycle.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   Reactome; R-HSA-75108; Activation, myristolyation of BID and translocation to mitochondria.
DR   SIGNOR; P30419; -.
DR   ChiTaRS; NMT1; human.
DR   EvolutionaryTrace; P30419; -.
DR   GeneWiki; N-myristoyltransferase_1; -.
DR   GenomeRNAi; 4836; -.
DR   PRO; PR:P30419; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000136448; -.
DR   CleanEx; HS_NMT1; -.
DR   ExpressionAtlas; P30419; baseline and differential.
DR   Genevisible; P30419; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0019898; C:extrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004379; F:glycylpeptide N-tetradecanoyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0019107; F:myristoyltransferase activity; TAS:Reactome.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0018008; P:N-terminal peptidyl-glycine N-myristoylation; IDA:UniProtKB.
DR   GO; GO:0006499; P:N-terminal protein myristoylation; TAS:Reactome.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR000903; MyristoylCoA_TrFase.
DR   InterPro; IPR022677; MyristoylCoA_TrFase_C.
DR   InterPro; IPR022678; MyristoylCoA_TrFase_CS.
DR   InterPro; IPR022676; MyristoylCoA_TrFase_N.
DR   PANTHER; PTHR11377; PTHR11377; 1.
DR   Pfam; PF01233; NMT; 1.
DR   Pfam; PF02799; NMT_C; 1.
DR   PIRSF; PIRSF015892; N-myristl_transf; 1.
DR   SUPFAM; SSF55729; SSF55729; 2.
DR   PROSITE; PS00975; NMT_1; 1.
DR   PROSITE; PS00976; NMT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Alternative splicing;
KW   Complete proteome; Cytoplasm; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase.
FT   CHAIN         1    496       Glycylpeptide N-tetradecanoyltransferase
FT                                1.
FT                                /FTId=PRO_0000064221.
FT   REGION      118    120       Myristoyl-CoA binding.
FT                                {ECO:0000269|PubMed:25255805,
FT                                ECO:0000269|Ref.16}.
FT   REGION      248    250       Myristoyl-CoA binding.
FT                                {ECO:0000269|PubMed:25255805,
FT                                ECO:0000269|Ref.16}.
FT   REGION      256    260       Myristoyl-CoA binding.
FT                                {ECO:0000269|PubMed:25255805,
FT                                ECO:0000269|Ref.16}.
FT   COMPBIAS     55     67       Poly-Lys.
FT   MOD_RES      31     31       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:O70310}.
FT   MOD_RES      47     47       Phosphoserine.
FT                                {ECO:0000244|PubMed:16964243,
FT                                ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      83     83       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1     80       Missing (in isoform Short).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_003570.
FT   VARIANT      61     61       Q -> K (in dbSNP:rs3087878).
FT                                /FTId=VAR_050286.
FT   MUTAGEN     492    492       G->D,K: Reduced activity.
FT                                {ECO:0000269|PubMed:1570339}.
FT   HELIX       120    122       {ECO:0000244|PDB:3IU1}.
FT   STRAND      123    125       {ECO:0000244|PDB:3IU1}.
FT   STRAND      156    160       {ECO:0000244|PDB:3IU1}.
FT   HELIX       166    179       {ECO:0000244|PDB:3IU1}.
FT   STRAND      188    190       {ECO:0000244|PDB:3IU1}.
FT   HELIX       194    201       {ECO:0000244|PDB:3IU1}.
FT   HELIX       208    210       {ECO:0000244|PDB:3IU1}.
FT   STRAND      211    216       {ECO:0000244|PDB:3IU1}.
FT   TURN        217    219       {ECO:0000244|PDB:3IU1}.
FT   STRAND      222    235       {ECO:0000244|PDB:3IU1}.
FT   STRAND      238    250       {ECO:0000244|PDB:3IU1}.
FT   HELIX       252    254       {ECO:0000244|PDB:3IU1}.
FT   HELIX       259    272       {ECO:0000244|PDB:3IU1}.
FT   TURN        273    275       {ECO:0000244|PDB:3IU1}.
FT   STRAND      279    285       {ECO:0000244|PDB:3IU1}.
FT   STRAND      291    302       {ECO:0000244|PDB:3IU1}.
FT   HELIX       303    308       {ECO:0000244|PDB:3IU1}.
FT   HELIX       320    327       {ECO:0000244|PDB:3IU1}.
FT   STRAND      338    340       {ECO:0000244|PDB:3IU1}.
FT   HELIX       343    345       {ECO:0000244|PDB:3IU1}.
FT   HELIX       346    356       {ECO:0000244|PDB:3IU1}.
FT   HELIX       357    359       {ECO:0000244|PDB:3IU1}.
FT   STRAND      360    365       {ECO:0000244|PDB:3IU1}.
FT   HELIX       368    375       {ECO:0000244|PDB:3IU1}.
FT   TURN        379    381       {ECO:0000244|PDB:3IU1}.
FT   STRAND      382    388       {ECO:0000244|PDB:3IU1}.
FT   STRAND      390    392       {ECO:0000244|PDB:1RXT}.
FT   STRAND      394    402       {ECO:0000244|PDB:3IU1}.
FT   STRAND      405    407       {ECO:0000244|PDB:3IU1}.
FT   STRAND      418    421       {ECO:0000244|PDB:3IU1}.
FT   STRAND      427    429       {ECO:0000244|PDB:3IU1}.
FT   HELIX       431    444       {ECO:0000244|PDB:3IU1}.
FT   STRAND      448    454       {ECO:0000244|PDB:3IU1}.
FT   HELIX       458    460       {ECO:0000244|PDB:3IU1}.
FT   TURN        461    466       {ECO:0000244|PDB:3IU1}.
FT   STRAND      468    480       {ECO:0000244|PDB:3IU1}.
FT   HELIX       488    490       {ECO:0000244|PDB:3IU1}.
SQ   SEQUENCE   496 AA;  56806 MW;  7661140D3837BE7A CRC64;
     MADESETAVK PPAPPLPQMM EGNGNGHEHC SDCENEEDNS YNRGGLSPAN DTGAKKKKKK
     QKKKKEKGSE TDSAQDQPVK MNSLPAERIQ EIQKAIELFS VGQGPAKTME EASKRSYQFW
     DTQPVPKLGE VVNTHGPVEP DKDNIRQEPY TLPQGFTWDA LDLGDRGVLK ELYTLLNENY
     VEDDDNMFRF DYSPEFLLWA LRPPGWLPQW HCGVRVVSSR KLVGFISAIP ANIHIYDTEK
     KMVEINFLCV HKKLRSKRVA PVLIREITRR VHLEGIFQAV YTAGVVLPKP VGTCRYWHRS
     LNPRKLIEVK FSHLSRNMTM QRTMKLYRLP ETPKTAGLRP METKDIPVVH QLLTRYLKQF
     HLTPVMSQEE VEHWFYPQEN IIDTFVVENA NGEVTDFLSF YTLPSTIMNH PTHKSLKAAY
     SFYNVHTQTP LLDLMSDALV LAKMKGFDVF NALDLMENKT FLEKLKFGIG DGNLQYYLYN
     WKCPSMGAEK VGLVLQ
//
